Takekazu Horio is a distinguished inventor based in Takatsuki, Japan. He has made significant contributions to the fields of medical diagnostics and biochemical technologies. With a total of 5 patents to his name, Horio's work has the potential to impact various aspects of healthcare and research.

Latest Patents

Horio's latest patents include innovative solutions for diagnosing cerebral apoplexy and determining protein molecular weights. One of his notable inventions is a marker for cerebral apoplexy, which involves treating a sample with a phosphoglyceric acid mutase (PGAM) inhibitor to inactivate the M-type isozyme activity. This allows for the quantification of the B-type PGAM, which serves as a novel marker for cerebral apoplexy diagnosis. Another significant patent is the colored molecular weight marker, which utilizes colored proteins with known molecular weights to determine the molecular weight of unknown proteins. This invention can also serve as a reference protein for the purification of proteins.

Career Highlights

Horio is currently associated with Oriental Yeast Co., Ltd., where he continues to innovate and develop new technologies. His work has garnered attention in the scientific community, particularly for its applications in medical diagnostics and protein analysis.

Collaborations

Horio has collaborated with notable colleagues, including Katsumi Fujii and Yasuo Suzuki. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Takekazu Horio's contributions to the fields of medical diagnostics and biochemical technologies highlight his role as a leading inventor. His innovative patents demonstrate a commitment to improving healthcare solutions and advancing scientific research.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com